Instructions for Isoprinosine (inosine pranobex)
English Product Name
Isoprinosine
Release Form
Tablets
Description Isoprinosine
Tablets are white or almost white, oblong, biconvex in shape, with a slight amine odor, and high risk on one side.
1 tab
inosine pranobex 500 mg
Accessories: mannitol, wheat starch, povidone, magnesium stearate.
ATX codes
J05AX05 Inosine pranobex
Clinical and pharmacological groups / Group affiliation
Immunostimulating drug
Active ingredient
inosine pranobex
Pharmacotherapeutic group Isoprinosine
Immunostimulant
Retention conditions
The drug should be stored in a dry, light-proof place out of the reach of children at temperatures not exceeding 25°C.
Expiration date
The shelf life is five years.
Pharmacological effect Isoprinosine
Isoprinosine is a synthetic complex derivative of purine, exhibiting immunostimulating activity and nonspecific antiviral action. It restores lymphocyte functions in the conditions of immunodepression, increases blastogenesis in the population of monocytic cells, stimulates expression of membrane receptors on the surface of T-helper cells
Testimony Isoprinosine
- Treatment of influenza and other SARSs
- Infections caused by Herpes simplex types 1, 2, 3, and 4: Genital and labial herpes, herpes simplex keratitis
- Shingles, chickenpox
- papillomavirus infection: laryngeal papillomas/vocal cords (fibrotic type), papillomavirus infection of the genitals in men and women, warts
- molluscum contagiosum.
- Infectious mononucleosis due to the Epstein-Barr virus
- Cytomegalovirus infection
- Severe measles
- Method of use, course and dosage Isoprinosine
The pills are taken after a meal, drinking a little water.
The recommended daily dose for adults and children aged three years and older (15-20 kg body weight) is 50 mg/kg body weight in three to four doses (6-8 tablets/day for adults, 1/2 tab for children per five kg body weight/day).
The pills are taken after a meal, drinking a little water.
For reurrent genital warts, the preparation is prescribed to adults in two tabs. three times per day, to children in 1/2 tabs. for five kg/body weight per day in three to four doses, either as monotherapy or in combination with surgical treatment for fourteen to twenty-eight days, then repeated three times the course at intervals of one month.
For cervical dysplasia associated with human papillomavirus, two tabs are prescribed. three times a day for ten days, then two to three similar courses are given at intervals of ten to fourteen days.
Nosology Isoprinosine (ICD codes)
A60
Anogenital herpetic virus infection [herpes simplex]
A63.0
Anogenital [venereal] warts (genital warts)
B00
Herpes simplex infections [herpes simplex]
B00.5
Herpetic eye disease
B01
Chickenpox [varicella]
B02
Herpes zoster [herpes zoster]
B05
Measles
B07
Viral warts
B08.1
Molluscum contagiosum
B25
Cytomegalovirus disease
B27
Infective mononucleosis
B97.7
Papillomaviruses as cause of diseases classified elsewhere
D14.1
Benign laryngeal neoplasm
H19.1
Herpes simplex keratitis and keratoconjunctivitis
J06.9
Acute upper respiratory infection, unspecified
J10
Influenza due to identified seasonal influenza virus
N87
Uterine cervix dysplasia, for children - 1/2 tab. per five kg of body weight per day).
